VECTIVBIO HOLDING AG NON-DISCLOSURE AGREEMENTNon-Disclosure Agreement • May 31st, 2023 • Ironwood Pharmaceuticals Inc • Pharmaceutical preparations
This Non-Disclosure Agreement (this "Agreement") is entered into between VectivBio Holding AG, a stock corporation (Aktiengesellschaft) incorporated and existing under the laws of Switzerland, having its registered office at Aeschenvorstadt 36, 4051 Basel, Switzerland, and registered with the commercial register of the Canton of Basel-Stadt under the company identification number CHE-289.024.902 (the "Company") and Ironwood Pharmaceuticals, Inc. (the "Recipient") as of March 29, 2023 (the "Effective Date"), to protect the confidentiality of certain confidential information of the Company to be disclosed to the Recipient solely for use in evaluating, pursuing and, if applicable, consummating a business relationship with the Company (the "Permitted Use").
April 29, 2023 Luca Santarelli, M.D. Chief Executive Officer VectivBio Holding AG Aeschenvorstadt 36Ironwood Pharmaceuticals Inc • May 31st, 2023 • Pharmaceutical preparations
